{'fraction_non_alphanumeric': 0.0202991452991453, 'fraction_numerical': 0.002136752136752137, 'mean_word_length': 5.331081081081081, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Effect of beta-adrenergic receptor blockade on development of training-induced bradycardia in rats.

Metoprolol-treated and untreated rats were subjected to the same treadmill running program for 12 weeks. After training and withdrawal of metoprolol, the treated rats had a more pronounced bradycardia during submaximal exercise than non-treated rats, although they had a lower heart weight/body weight ratio. The intrinsic heart rate (IHR) was slightly but not significantly lower in trained than in untrained untreated animals. The IHR was not altered by a period of metoprolol treatment neither alone nor in combination with training. It is concluded that chronic cardioselective beta-blockade during training augments the training-induced bradycardia but may impair the development of cardiac hypertrophy. The training-induced bradycardia is thus not related to the degree of heart rate increase during exercise for its development.